it is concluded that an increase in plasma and urine sir , the presence of a 6000- to 7000-dalton sir fraction in plasma and urine , a reduction in basal and stimulated pancreatic hormone levels , and tolbutamide-induced somatostatin release can be diagnostic for a somatostatinoma .
C0030292
pancreatic hormone
C0037659
somatostatin